Lantheus Holdings, Inc. (LNTH) financials

Lantheus Holdings, Inc. (LNTH) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Lantheus Holdings, Inc. reported revenue of $1.54B, up 0.5% year over year, net income of $234M and diluted EPS of $3.41.

Revenue (fiscal 2025)

$1.54B

Revenue growth (fiscal 2025)

0.5%

Net income (fiscal 2025)

$234M

Diluted EPS (fiscal 2025)

$3.41

Lantheus Holdings, Inc. files with the U.S. Securities and Exchange Commission under CIK 0001521036, classified as In Vitro & In Vivo Diagnostic Substances.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.